Pharmacokinetics and Pharmacodynamics of TRV130, Morphine, and Placebo in Healthy Subjects

NCT02083315 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain, Acute

Interventions

DRUG: TRV130 1.5 mg
DRUG: TRV130 3 mg
DRUG: TRV130 4.5 mg
DRUG: Morphine 10 mg
DRUG: Placebo

Sponsor

Trevena Inc.